Ashley M. Lambros

516 total citations
16 papers, 310 citations indexed

About

Ashley M. Lambros is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Ashley M. Lambros has authored 16 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Psychiatry and Mental health. Recurrent topics in Ashley M. Lambros's work include Cannabis and Cannabinoid Research (12 papers), Prenatal Substance Exposure Effects (4 papers) and Psychosomatic Disorders and Their Treatments (3 papers). Ashley M. Lambros is often cited by papers focused on Cannabis and Cannabinoid Research (12 papers), Prenatal Substance Exposure Effects (4 papers) and Psychosomatic Disorders and Their Treatments (3 papers). Ashley M. Lambros collaborates with scholars based in United States and France. Ashley M. Lambros's co-authors include Staci A. Gruber, Mary Kathryn Dahlgren, Rosemary T. Smith, Kelly A. Sagar, A. Gönenç, Sherry Winternitz, Milissa L. Kaufman, Lauren A. M. Lebois, Kerry J. Ressler and Jonathan D. Wolff and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Scientific Reports.

In The Last Decade

Ashley M. Lambros

15 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashley M. Lambros United States	9	191	79	68	62	57	16	310
Emese Kroon Netherlands	9	254 1.3×	59 0.7×	92 1.4×	65 1.0×	51 0.9×	28	369
Lauren Kuhns Netherlands	9	249 1.3×	59 0.7×	90 1.3×	63 1.0×	50 0.9×	24	367
Sophie L. YorkWilliams United States	12	264 1.4×	104 1.3×	50 0.7×	56 0.9×	34 0.6×	17	453
Josef Hättenschwiler Switzerland	11	80 0.4×	93 1.2×	74 1.1×	62 1.0×	71 1.2×	24	366
Alexandria S. Coles Canada	8	170 0.9×	83 1.1×	104 1.5×	136 2.2×	48 0.8×	14	457
Musa Sami United Kingdom	9	285 1.5×	67 0.8×	76 1.1×	223 3.6×	37 0.6×	24	461
Megan T. Racine United States	6	302 1.6×	85 1.1×	61 0.9×	76 1.2×	41 0.7×	7	394
Maria Lidia Gerra Italy	10	99 0.5×	40 0.5×	75 1.1×	64 1.0×	40 0.7×	20	324
Grace Blest‐Hopley United Kingdom	10	280 1.5×	89 1.1×	34 0.5×	86 1.4×	33 0.6×	18	342
Anna Borissova United Kingdom	10	134 0.7×	41 0.5×	70 1.0×	43 0.7×	22 0.4×	23	218

Countries citing papers authored by Ashley M. Lambros

Since Specialization

Citations

This map shows the geographic impact of Ashley M. Lambros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley M. Lambros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley M. Lambros more than expected).

Fields of papers citing papers by Ashley M. Lambros

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley M. Lambros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley M. Lambros. The network helps show where Ashley M. Lambros may publish in the future.

Co-authorship network of co-authors of Ashley M. Lambros

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley M. Lambros. A scholar is included among the top collaborators of Ashley M. Lambros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley M. Lambros. Ashley M. Lambros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Dahlgren, Mary Kathryn, et al.. (2024). A National Survey Study of Cannabis Use During Menopause: Identifying Variables Associated With Recreational, Medical, and Hybrid Use. Journal of Studies on Alcohol and Drugs. 86(1). 68–74. 1 indexed citations

Dahlgren, Mary Kathryn, et al.. (2023). Identifying Variables Associated with Menopause-Related Shame and Stigma: Results from a National Survey Study. Journal of Women s Health. 32(11). 1182–1191. 8 indexed citations

Lambros, Ashley M., et al.. (2023). CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure. Scientific Reports. 13(1). 5869–5869. 3 indexed citations

Dahlgren, Mary Kathryn, et al.. (2022). Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial. SHILAP Revista de lepidopterología. 2(1). 139–139. 29 indexed citations

Dahlgren, Mary Kathryn, A. Gönenç, Kelly A. Sagar, et al.. (2022). Increased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment. Cannabis and Cannabinoid Research. 7(6). 827–839. 7 indexed citations

Lebois, Lauren A. M., Poornima Kumar, Ashley M. Lambros, et al.. (2022). Deconstructing dissociation: a triple network model of trauma-related dissociation and its subtypes. Neuropsychopharmacology. 47(13). 2261–2270. 20 indexed citations

Dahlgren, Mary Kathryn, et al.. (2022). A survey of medical cannabis use during perimenopause and postmenopause. Menopause The Journal of The North American Menopause Society. 29(9). 1028–1036. 13 indexed citations

Sagar, Kelly A., et al.. (2021). An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary Results. Journal of the International Neuropsychological Society. 27(6). 648–660. 23 indexed citations

Gruber, Staci A., Rosemary T. Smith, Mary Kathryn Dahlgren, Ashley M. Lambros, & Kelly A. Sagar. (2021). No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms.. Experimental and Clinical Psychopharmacology. 29(2). 147–156. 25 indexed citations

10.

Sagar, Kelly A., Mary Kathryn Dahlgren, Rosemary T. Smith, Ashley M. Lambros, & Staci A. Gruber. (2021). Assessing Cannabis Use Disorder in Medical Cannabis Patients: Interim Analyses from an Observational, Longitudinal Study. PubMed. 4(2). 47–59. 4 indexed citations

11.

Dahlgren, Mary Kathryn, A. Gönenç, Kelly A. Sagar, et al.. (2021). White Matter Integrity in Medical Cannabis Patients: Increased Fractional Anisotropy After Three Months of Treatment. Biological Psychiatry. 89(9). S280–S281. 1 indexed citations

12.

Lebois, Lauren A. M., Meiling Li, Justin T. Baker, et al.. (2020). Large-Scale Functional Brain Network Architecture Changes Associated With Trauma-Related Dissociation. American Journal of Psychiatry. 178(2). 165–173. 69 indexed citations

13.

Dahlgren, Mary Kathryn, et al.. (2020). Recreational cannabis use impairs driving performance in the absence of acute intoxication. Drug and Alcohol Dependence. 208. 107771–107771. 42 indexed citations

14.

Sagar, Kelly A., Ashley M. Lambros, Mary Kathryn Dahlgren, Rosemary T. Smith, & Staci A. Gruber. (2018). Made from concentrate? A national web survey assessing dab use in the United States. Drug and Alcohol Dependence. 190. 133–142. 18 indexed citations

15.

Gruber, Staci A., Kelly A. Sagar, Mary Kathryn Dahlgren, et al.. (2018). The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment. Frontiers in Pharmacology. 8. 983–983. 47 indexed citations

16.

Lebois, Lauren A. M., Jonathan D. Wolff, Ashley M. Lambros, et al.. (2018). T69. Dissociative Subtypes of Detachment and Compartmentalization are Associated With Different Neural Activity in a Masked Fearful Face Paradigm. Biological Psychiatry. 83(9). S155–S156.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact